OSCR

Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an <i>in vivo</i> and <i>in silico</i> study implicating cholinergic signaling.

Overview

Authors: Fan Yang1, Fen Jiang1,2, Xuewei Li1
  1. Department of Neurology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China
  2. Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China
Journal: Frontiers in psychology, volume 17, article 1821889
Dates: received 3 March 2026; accepted 27 April 2026; published online 14 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fpsyg.2026.1821889 · PMID 42220383 · PMCID PMC13216502 · OpenAlex W7161149691
Open access: gold, a free copy (OpenAlex)
Categories: rat (organism), depression (population), sleep disorders (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: aging-related insomnia, cholinergic pathway, cognitive dysfunction, gomisin E, inflammatory response
Topic: Antioxidants, Aging, Portulaca oleracea (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Citations: not cited yet (Europe PMC); 39 references in the paper

Abstract

Objective: To investigate the therapeutic effects of gomisin E on insomnia in aged rats and to elucidate the underlying mechanisms.

Methods: An aging-related insomnia rat model was established by intraperitoneal injection of D-galactose combined with p-chlorophenylalanine (PCPA). Rats were treated with gomisin E at different doses (5, 15, and 45 mg/kg). Sleep quality, depressive-like behaviors, and cognitive function were evaluated using the pentobarbital sodium-induced sleep test, sucrose preference test, and Morris water maze test, respectively. Potential targets and signaling pathways were screened using bioinformatics analysis. The contents of acetylcholine (ACh) and choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities in the hippocampus and ileum were determined using commercial assay kits. Protein levels of muscarinic acetylcholine receptor M1 and M2 (CHRM1 and CHRM2) in the hippocampus were detected by Western blot analysis.

Results: Gomisin E dose-dependently alleviated body weight loss, sleep disorders, depressive-like behaviors, and cognitive dysfunction in aged rats with insomnia, significantly reducing pro-inflammatory cytokine levels. The potential mechanisms of gomisin E involved circadian rhythm regulation, inflammatory responses, the C-type lectin receptor signaling pathway, and cholinergic synapses. Gomisin E increased ACh content and ChAT activity, decreased AChE activity in the hippocampus and ileum, and upregulated the protein expression of CHRM1 and CHRM2 in the hippocampus.

Conclusion: Gomisin E effectively ameliorates D-galactose/PCPA-induced insomnia and the associated depressive-like behaviors and cognitive dysfunction. The underlying mechanisms may involve suppression of systemic inflammation and restoration of cholinergic system homeostasis.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 3 authors, 5 keywords, 39 references.

Cite

This paper

Yang, F., Jiang, F., & Li, X. (2026). Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an <i>in vivo</i> and <i>in silico</i> study implicating cholinergic signaling. Frontiers in psychology, 17, 1821889. https://doi.org/10.3389/fpsyg.2026.1821889

BibTeX

@article{yang2026gomisin,
author = {Yang, Fan and Jiang, Fen and Li, Xuewei},
title = {{Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an \<i\>in vivo\</i\> and \<i\>in silico\</i\> study implicating cholinergic signaling}},
journal = {Frontiers in psychology},
year = {2026},
month = may,
volume = {17},
pages = {1821889},
publisher = {Frontiers Media SA},
issn = {1664-1078},
doi = {10.3389/fpsyg.2026.1821889},
url = {https://doi.org/10.3389/fpsyg.2026.1821889},
pmid = {42220383},
pmcid = {PMC13216502}
}

RIS

TY - JOUR
AU - Yang, Fan
AU - Jiang, Fen
AU - Li, Xuewei
TI - Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an <i>in vivo</i> and <i>in silico</i> study implicating cholinergic signaling
T2 - Frontiers in psychology
J2 - Front Psychol
PY - 2026
DA - 2026/05/14
VL - 17
SP - 1821889
SN - 1664-1078
PB - Frontiers Media SA
DO - 10.3389/fpsyg.2026.1821889
UR - https://doi.org/10.3389/fpsyg.2026.1821889
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fpsyg.2026.1821889",
"type": "article-journal",
"title": "Gomisin E attenuates pentobarbital-induced sleep deficits in aging-related insomnia: an <i>in vivo</i> and <i>in silico</i> study implicating cholinergic signaling",
"container-title": "Frontiers in psychology",
"author": [
{
"family": "Yang",
"given": "Fan"
},
{
"family": "Jiang",
"given": "Fen"
},
{
"family": "Li",
"given": "Xuewei"
}
],
"container-title-short": "Front Psychol",
"volume": "17",
"page": "1821889",
"DOI": "10.3389/fpsyg.2026.1821889",
"PMID": "42220383",
"PMCID": "PMC13216502",
"ISSN": "1664-1078",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fpsyg.2026.1821889",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
14
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.2147/nss.s582222
Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia.
Journal: Nature and science of sleep
In common: NCBI GEO GSE208668, sleep disorders, rat, cellular / molecular, 1 reference
[2] doi:10.3390/ijms26051842
The Extract of <i>Piper nigrum</i> Improves the Cognitive Impairment and Mood in Sleep-Deprived Mice Through the JAK1/STAT3 Signalling Pathway.
Journal: International journal of molecular sciences
In common: NCBI GEO GSE208668, depression, rat, cellular / molecular
[3] doi:10.3389/fmicb.2025.1541958
Effect of acupuncture at Back-Shu points on gut microbiota in insomnia model rats based on metagenomic sequencing technology.
Journal: Frontiers in microbiology
In common: sleep disorders, rat, cellular / molecular, 1 reference
[4] doi:10.1186/s12916-026-04787-y
A human-derived Bacteroides strain attenuates depressive-like behavior in a rat model of social defeat-induced stress.
Journal: BMC medicine
In common: depression, rat, 1 reference
[5] doi:10.1155/np/9450146 [code]
Ginsenoside Rg1 Improves PTSD-Like Sleep Disturbances in Male Mice: Involvement of NLRP3-Related Inflammatory and Apoptotic Pathways.
Journal: Neural plasticity
In common: sleep disorders, cellular / molecular, 1 reference
[6] doi:10.3390/ph17091161
Beta-Myrcene as a Sedative-Hypnotic Component from Lavender Essential Oil in DL-4-Chlorophenylalanine-Induced-Insomnia Mice.
Journal: Pharmaceuticals (Basel, Switzerland)
In common: sleep disorders, cellular / molecular, 1 reference
[7] doi:10.3389/fmicb.2026.1850738
Correlation study of polysomnographic parameters, serological markers, and gut microbiota in patients with short-sleep insomnia: a real-world study.
Journal: Frontiers in microbiology
In common: sleep disorders, 1 reference
[8] doi:10.1016/j.ebiom.2024.105313 [code]
Prediction of depressive symptoms severity based on sleep quality, anxiety, and gray matter volume: a generalizable machine learning approach across three datasets.
Journal: EBioMedicine
In common: depression, 1 reference
[9] doi:10.3390/biomedicines12122830
ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke.
Journal: Biomedicines
In common: rat, cellular / molecular, 1 reference
[10] doi:10.3390/genes13122380
Insight into Glyproline Peptides' Activity through the Modulation of the Inflammatory and Neurosignaling Genetic Response Following Cerebral Ischemia-Reperfusion.
Journal: Genes
In common: rat, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.